UCSF Pharmacogenetics of Membrane Transporters
Snp Publications
  1. Liu R, Tang AM, Tan YL, Limenta LM, Lee EJ. Interethnic differences of PEPT2 (SLC15A2) polymorphism distribution and associations with cephalexin pharmacokinetics in healthy Asian subjects. Eur J Clin Pharmacol. 2009 Jan;65(1):65-70. PMID: 18766334.
  2. Sala-Rabanal M, Loo DD, Hirayama BA, Wright EM. Molecular mechanism of dipeptide and drug transport by the human renal H+/oligopeptide cotransporter hPEPT2. Am J Physiol Renal Physiol. 2008 Jun;294(6):F1422-32. PMID: 18367661.
  3. Pinsonneault J, Nielsen CU, Sadée W. Genetic variants of the human H+/dipeptide transporter PEPT2: analysis of haplotype functions. J Pharmacol Exp Ther. 2004 Dec;311(3):1088-96. PMID: 15282265.
  4. Terada T, Irie M, Okuda M, Inui K. Genetic variant Arg57His in human H+/peptide cotransporter 2 causes a complete loss of transport function. Biochem Biophys Res Commun. 2004 Apr 2;316(2):416-20. PMID: 15020234.